Remote disease management and virtual care reimagined
AI-powered digital health
Phyla has developed an algorithm that can accurately diagnose inflammatory bowel disease using the stool microbiome along with a digital health app for remote IBD/IBS patient management.
As we await regulatory approval, Phyla’s algorithm has been repurposed to provide an indicator of the individual’s intestinal health. Instead of a diagnosis, we provide a wellness score which will indicate the level of intestinal microbial disorder as a proxy for an individual’s current disease severity.
REMOTE CARE DELIVERY
Efficient longitudinal monitoring
Phyla provides insight into patients’ lifestyle and regular snapshots of their intestinal health.
Patients can track months of symptom and lifestyle data in between medical appointments and share this with their physicians in an easily digestible format.
The at-home, low-cost and accurate nature of Phyla’s microbiome testing decreases the need for in-person medical visits, diminishes the burden on the healthcare system and lowers stress levels for patients.
Gut Microbiome Composition
DATA-DRIVEN DISEASE MANAGEMENT
Predictive & Personalized Care
Phyla provides alerts when several serious symptoms are detected by the algorithm.
The relevant information obtained from our approach helps people track treatment adherence and response.
Through Phyla's longitudinal testing and tracking, physicians will be able to care for their patients in a more complete manner, resulting in improved disease management and disease state.
CURRENT RESEARCH COLLABORATIONS
MUHC IBD clinic:
To further validate the accuracy of our algorithms, we are completing a government funded study in Montreal in 2021, with 250 participants at the McGill University Health Center.
We have been invited as ‘Innovation Fellows in Residence’ by the St. Justine Mother and Child University Hospital Center to deploy our app to their IBD patients transitioning from pediatric to adult care.
Get in touch with our Medical Team
Our team of medical experts led by Dr. Houman Farzin are here to answer all your questions. Reach out to chat with us about our solution and the literature behind our science.